Ушбу иш иқтибос қилган ишлар

122 та иш

Иш: Pharmacomicrobiomics in blood cancers: How the gut microbiome and its metabolites shape drug efficacy and toxicity

Lactobacillus rhamnosus GG probiotic enteric regimen does not appreciably alter the gut microbiome or provide protection against GVHD after allogeneic hematopoietic stem cell transplantation
Elan Gorshein, Catherine Wei, Susan Ambrosy +13
Мақола20172 иқтибос
ABI
Thiopurine S-Methyltransferase as a Pharmacogenetic Biomarker: Significance of Testing and Review of Major Methods
Chingiz Asadov, Gunay Aliyeva, Kamala Mustafayeva
Шарҳ мақола20172 иқтибос
ABI
Pathogen-Induced TLR4-TRIF Innate Immune Signaling in Hematopoietic Stem Cells Promotes Proliferation but Reduces Competitive Fitness
Hitoshi Takizawa, Kristin Fritsch, Larisa V. Kovtonyuk +10
Мақола20172 иқтибос
ABI
Low-Dose Cyclophosphamide Induces Antitumor T-Cell Responses, which Associate with Survival in Metastatic Colorectal Cancer
Martin Scurr, Tom Pembroke, Anja Bloom +13
Мақола20172 иқтибос
ABI
Gut microbiota sways response to cancer immunotherapy
Ashley York
Шарҳ мақола20182 иқтибос
ABI
Short Chain Fatty Acids are Reduced after Hematopoietic Stem Cell Transplant in Humans and are Associated with Modifications of the Gut Microbiome
Lindsey E. Romick‐Rosendale, David Haslam, Adam Lane +7
Мақола20182 иқтибос
ABI
Induction and Amelioration of Methotrexate-Induced Gastrointestinal Toxicity are Related to Immune Response and Gut Microbiota
Bailing Zhou, Xuyang Xia, Peiqi Wang +16
Мақола20182 иқтибос
ABI
Microbiota and cancer immunotherapy: in search of microbial signals
Raad Z. Gharaibeh, Christian Jobin
Шарҳ мақола20182 иқтибос
ABI
Commensal Gut Bacteria Convert the Immunosuppressant Tacrolimus to Less Potent Metabolites
Yukuang Guo, Camila Manoel Crnkovic, Kyoung‐Jae Won +5
Мақола20182 иқтибос
ABI
Akkermansia muciniphila induces intestinal adaptive immune responses during homeostasis
Eduard Ansaldo, Leianna C. Slayden, Krystal L. Ching +8
Мақола20192 иқтибос
ABI
Vancomycin relieves mycophenolate mofetil–induced gastrointestinal toxicity by eliminating gut bacterial β-glucuronidase activity
Michael R. Taylor, Kyle L. Flannigan, Hannah Rahim +4
Мақола20192 иқтибос
ABI
Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation
Jonathan U. Peled, Antonio L. C. Gomes, Sean M. Devlin +49
Мақола20202 иқтибос
ABI
Targeted inhibition of gut bacterial β-glucuronidase activity enhances anticancer drug efficacy
Aadra P. Bhatt, Samuel J. Pellock, Kristen A. Biernat +16
Мақола20202 иқтибос
ABI
A Two-Way Interaction between Methotrexate and the Gut Microbiota of Male Sprague–Dawley Rats
Marine P. M. Letertre, Nyasha Munjoma, Kate Wolfer +9
Мақола20202 иқтибос
ABI
A unified catalog of 204,938 reference genomes from the human gut microbiome
Alexandre Almeida, Stephen Nayfach, Miguel Boland +10
Мақола20202 иқтибос
ABI
Holo-Omics: Integrated Host-Microbiota Multi-omics for Basic and Applied Biological Research
Lasse Nyholm, Adam Koziol, Sofia Marcos +6
Шарҳ мақола20202 иқтибос
ABI
Microbial metabolite boosts immunotherapy
Lucy Bird
Шарҳ мақола20202 иқтибос
ABI
The Pretreatment Gut Microbiome Is Associated With Lack of Response to Methotrexate in New‐Onset Rheumatoid Arthritis
Alejandro Artacho, Sandrine Isaac, Renuka R. Nayak +17
Мақола20202 иқтибос
ABI
Methotrexate impacts conserved pathways in diverse human gut bacteria leading to decreased host immune activation
Renuka R. Nayak, Margaret Alexander, Ishani Deshpande +6
Мақола20212 иқтибос
ABI
Entropy-driven binding of gut bacterial β-glucuronidase inhibitors ameliorates irinotecan-induced toxicity
Hsien‐Ya Lin, Chia-Yu Chen, Ting‐Chien Lin +11
Мақола20212 иқтибос
ABI
TPMT*3C as a Predictor of 6-Mercaptopurine-Induced Myelotoxicity in Thai Children with Acute Lymphoblastic Leukemia
Thawinee Jantararoungtong, Supaporn Wiwattanakul, Rawiporn Tiyasirichokchai +10
Мақола20212 иқтибос
ABI
The Role of the Gut Microbiome in Pathogenesis, Biology, and Treatment of Plasma Cell Dyscrasias
Marcin Jasiński, Jarosław Biliński, Grzegorz Basak
Шарҳ мақола20212 иқтибос
ABI
Gut microbiome in allogeneic hematopoietic stem cell transplantation and specific changes associated with acute graft vs host disease
Quentin Le Bastard, Patrice Chevallier, Emmanuel Montassier
Шарҳ мақола20212 иқтибос
ABI
Pharmacomicrobiology of Methotrexate in Rheumatoid Arthritis: Gut Microbiome as Predictor of Therapeutic Response
Huanhuan Yan, Rui Su, Hongwei Xue +3
Шарҳ мақола20212 иқтибос
ABI
SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection
Paul Feuerstadt, Thomas J. Louie, Bret Lashner +20
Мақола20222 иқтибос
ABI

Ушбу иш иқтибос қилган ишлар

<i>Lactobacillus rhamnosus GG</i> probiotic enteric regimen does not appreciably alter the gut microbiome or provide protection against GVHD after allogeneic hematopoietic stem cell transplantation

Thiopurine S-Methyltransferase as a Pharmacogenetic Biomarker: Significance of Testing and Review of Major Methods

Pathogen-Induced TLR4-TRIF Innate Immune Signaling in Hematopoietic Stem Cells Promotes Proliferation but Reduces Competitive Fitness

Low-Dose Cyclophosphamide Induces Antitumor T-Cell Responses, which Associate with Survival in Metastatic Colorectal Cancer

Gut microbiota sways response to cancer immunotherapy

Short Chain Fatty Acids are Reduced after Hematopoietic Stem Cell Transplant in Humans and are Associated with Modifications of the Gut Microbiome

Induction and Amelioration of Methotrexate-Induced Gastrointestinal Toxicity are Related to Immune Response and Gut Microbiota

Microbiota and cancer immunotherapy: in search of microbial signals

Commensal Gut Bacteria Convert the Immunosuppressant Tacrolimus to Less Potent Metabolites

<i>Akkermansia muciniphila</i> induces intestinal adaptive immune responses during homeostasis

Vancomycin relieves mycophenolate mofetil–induced gastrointestinal toxicity by eliminating gut bacterial β-glucuronidase activity

Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation

Targeted inhibition of gut bacterial β-glucuronidase activity enhances anticancer drug efficacy

A Two-Way Interaction between Methotrexate and the Gut Microbiota of Male Sprague–Dawley Rats

A unified catalog of 204,938 reference genomes from the human gut microbiome

Holo-Omics: Integrated Host-Microbiota Multi-omics for Basic and Applied Biological Research

Microbial metabolite boosts immunotherapy

The Pretreatment Gut Microbiome Is Associated With Lack of Response to Methotrexate in New‐Onset Rheumatoid Arthritis

Methotrexate impacts conserved pathways in diverse human gut bacteria leading to decreased host immune activation

Entropy-driven binding of gut bacterial β-glucuronidase inhibitors ameliorates irinotecan-induced toxicity

TPMT*3C as a Predictor of 6-Mercaptopurine-Induced Myelotoxicity in Thai Children with Acute Lymphoblastic Leukemia

The Role of the Gut Microbiome in Pathogenesis, Biology, and Treatment of Plasma Cell Dyscrasias

Gut microbiome in allogeneic hematopoietic stem cell transplantation and specific changes associated with acute graft <i>vs</i> host disease

Pharmacomicrobiology of Methotrexate in Rheumatoid Arthritis: Gut Microbiome as Predictor of Therapeutic Response

SER-109, an Oral Microbiome Therapy for Recurrent <i>Clostridioides difficile</i> Infection